WebApr 15, 2024 · Telara Pharma is focused on the research, development, and marketing of drugs for the treatment of high prevalence pathologies (mainly kidney injuries and … WebTelara Pharma has signed an exclusive worldwide license agreement with the Canadian company Arch Biopartners to use cilastatin in the treatment and prevention of acute kidney injury and in sepsis processes. Cilastatin is a small molecule inhibitor of the dipeptidase-1 (DPEP-1) enzyme developed in the 1980s to prevent degradation of the Imipenem ...
Telara Pharma Stock Price, Funding, Valuation, Revenue
WebApr 15, 2024 · (2024-04-15 TSXV:ARCH) Arch Biopartners Enters Into Worldwide License Agreement With Telara Pharma To Re-Purpose Cilastatin For The Treatment And … WebSolution – Telara Pharma. We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. microsoft word list templates free download
Genesis Biomed drives Telara Pharma, a spin-off from the …
WebApr 15, 2024 · Arch Biopartners Inc. announced it has entered into an exclusive worldwide license agreement with Telara Pharma of Spain (“Telara”) to clinically develop and … WebMay 11, 2024 · Thanks to the support of Genesis Biomed, Telara Pharma -a spin-off from Gregorio Marañón General University Hospital – has signed an exclusive worldwide licence agreement with the Canadian company Arch Biopartners for the use of cilastatin as treatment and prevention of acute kidney injury and sepsis processes. WebJun 26, 2024 · Telara Pharma designs a drug capable in the treatment and prevention of acute kidney injury. AVX Pharma Crunchbase Website Twitter Facebook Linkedin AVX Pharma is a biopharmaceutical company focused on developing novel drugs addressing major ophthalmic unmet medical needs Vaxdyn Crunchbase Website Twitter Facebook … newshilohcc live streaming